PHOTRONICS INC (PLAB) Fundamental Analysis & Valuation

NASDAQ:PLAB • US7194051022

35.26 USD
-1.67 (-4.52%)
At close: Mar 3, 2026
35.15 USD
-0.11 (-0.31%)
After Hours: 3/3/2026, 8:00:01 PM

This PLAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PLAB. PLAB was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PLAB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. PLAB Profitability Analysis

1.1 Basic Checks

  • In the past year PLAB was profitable.
  • PLAB had a positive operating cash flow in the past year.
  • PLAB had positive earnings in each of the past 5 years.
  • PLAB had a positive operating cash flow in each of the past 5 years.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • PLAB's Return On Assets of 7.56% is fine compared to the rest of the industry. PLAB outperforms 73.91% of its industry peers.
  • PLAB has a better Return On Equity (11.62%) than 76.52% of its industry peers.
  • PLAB has a better Return On Invested Capital (10.17%) than 82.61% of its industry peers.
  • PLAB had an Average Return On Invested Capital over the past 3 years of 12.29%. This is in line with the industry average of 10.52%.
Industry RankSector Rank
ROA 7.56%
ROE 11.62%
ROIC 10.17%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 16.06%, PLAB is doing good in the industry, outperforming 75.65% of the companies in the same industry.
  • PLAB's Profit Margin has improved in the last couple of years.
  • PLAB has a better Operating Margin (24.51%) than 82.61% of its industry peers.
  • PLAB's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 35.30%, PLAB is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
  • PLAB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.51%
PM (TTM) 16.06%
GM 35.3%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. PLAB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PLAB is still creating some value.
  • PLAB has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PLAB has been reduced compared to 5 years ago.
  • The debt/assets ratio for PLAB has been reduced compared to a year ago.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • PLAB has an Altman-Z score of 3.87. This indicates that PLAB is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 3.87, PLAB perfoms like the industry average, outperforming 53.91% of the companies in the same industry.
  • PLAB has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
  • PLAB has a better Debt to FCF ratio (0.00) than 86.09% of its industry peers.
  • PLAB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • PLAB has a Debt to Equity ratio of 0.00. This is in the better half of the industry: PLAB outperforms 73.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.87
ROIC/WACC0.92
WACC11.11%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • PLAB has a Current Ratio of 5.37. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of PLAB (5.37) is better than 73.91% of its industry peers.
  • PLAB has a Quick Ratio of 4.99. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.99, PLAB is in the better half of the industry, outperforming 75.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.37
Quick Ratio 4.99
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

4

3. PLAB Growth Analysis

3.1 Past

  • PLAB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.92%.
  • PLAB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.81% yearly.
  • Looking at the last year, PLAB shows a decrease in Revenue. The Revenue has decreased by -2.04% in the last year.
  • PLAB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)1.92%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%17.31%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%6.1%

3.2 Future

  • Based on estimates for the next years, PLAB will show a small growth in Earnings Per Share. The EPS will grow by 5.62% on average per year.
  • PLAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.23% yearly.
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.7%
Revenue Next 2Y6.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

6

4. PLAB Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.63 indicates a correct valuation of PLAB.
  • Compared to the rest of the industry, the Price/Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 93.04% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of PLAB to the average of the S&P500 Index (26.83), we can say PLAB is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 15.57, the valuation of PLAB can be described as correct.
  • Based on the Price/Forward Earnings ratio, PLAB is valued cheaper than 90.43% of the companies in the same industry.
  • PLAB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.63
Fwd PE 15.57
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • PLAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PLAB is cheaper than 100.00% of the companies in the same industry.
  • PLAB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PLAB is cheaper than 80.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.28
EV/EBITDA 4.75
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PLAB does not grow enough to justify the current Price/Earnings ratio.
  • PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.37
PEG (5Y)0.54
EPS Next 2Y5.62%
EPS Next 3YN/A

0

5. PLAB Dividend Analysis

5.1 Amount

  • PLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PLAB Fundamentals: All Metrics, Ratios and Statistics

PHOTRONICS INC

NASDAQ:PLAB (3/3/2026, 8:00:01 PM)

After market: 35.15 -0.11 (-0.31%)

35.26

-1.67 (-4.52%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners94.12%
Inst Owner Change2.09%
Ins Owners3.91%
Ins Owner Change0.82%
Market Cap2.04B
Revenue(TTM)849.29M
Net Income(TTM)136.40M
Analysts85
Price Target43.2 (22.52%)
Short Float %5.43%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.53%
Min EPS beat(2)29.38%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)12.6%
Min EPS beat(4)-19.14%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)2.09%
EPS beat(12)6
Avg EPS beat(12)2.67%
EPS beat(16)9
Avg EPS beat(16)6.93%
Revenue beat(2)2
Avg Revenue beat(2)1.95%
Min Revenue beat(2)0.82%
Max Revenue beat(2)3.08%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)3.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.37%
Revenue beat(12)5
Avg Revenue beat(12)-1.19%
Revenue beat(16)8
Avg Revenue beat(16)-0.48%
PT rev (1m)0%
PT rev (3m)28.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.72%
EPS NY rev (1m)0%
EPS NY rev (3m)6.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.76%
Valuation
Industry RankSector Rank
PE 16.63
Fwd PE 15.57
P/S 2.4
P/FCF 34.28
P/OCF 8.24
P/B 1.74
P/tB 1.74
EV/EBITDA 4.75
EPS(TTM)2.12
EY6.01%
EPS(NY)2.26
Fwd EY6.42%
FCF(TTM)1.03
FCFY2.92%
OCF(TTM)4.28
OCFY12.13%
SpS14.66
BVpS20.26
TBVpS20.26
PEG (NY)2.37
PEG (5Y)0.54
Graham Number31.09
Profitability
Industry RankSector Rank
ROA 7.56%
ROE 11.62%
ROCE 12.7%
ROIC 10.17%
ROICexc 15.86%
ROICexgc 15.86%
OM 24.51%
PM (TTM) 16.06%
GM 35.3%
FCFM 7.01%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
ROICexc(3y)20.09%
ROICexc(5y)18.3%
ROICexgc(3y)20.09%
ROICexgc(5y)18.3%
ROCE(3y)15.36%
ROCE(5y)14.68%
ROICexgc growth 3Y-10.62%
ROICexgc growth 5Y18.95%
ROICexc growth 3Y-10.62%
ROICexc growth 5Y19.05%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 242.55%
Cap/Sales 22.16%
Interest Coverage 250
Cash Conversion 86.71%
Profit Quality 43.67%
Current Ratio 5.37
Quick Ratio 4.99
Altman-Z 3.87
F-Score6
WACC11.11%
ROIC/WACC0.92
Cap/Depr(3y)187.79%
Cap/Depr(5y)164.84%
Cap/Sales(3y)17.34%
Cap/Sales(5y)16.42%
Profit Quality(3y)93.18%
Profit Quality(5y)98.28%
High Growth Momentum
Growth
EPS 1Y (TTM)1.92%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%17.31%
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%6.1%
Revenue Next Year5.7%
Revenue Next 2Y6.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.03%
EBIT growth 3Y-0.59%
EBIT growth 5Y26.64%
EBIT Next Year48.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.32%
FCF growth 3Y-28.46%
FCF growth 5Y-3.72%
OCF growth 1Y-5.22%
OCF growth 3Y-3.44%
OCF growth 5Y11.62%

PHOTRONICS INC / PLAB FAQ

What is the fundamental rating for PLAB stock?

ChartMill assigns a fundamental rating of 6 / 10 to PLAB.


Can you provide the valuation status for PHOTRONICS INC?

ChartMill assigns a valuation rating of 6 / 10 to PHOTRONICS INC (PLAB). This can be considered as Fairly Valued.


How profitable is PHOTRONICS INC (PLAB) stock?

PHOTRONICS INC (PLAB) has a profitability rating of 7 / 10.


What is the valuation of PHOTRONICS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PHOTRONICS INC (PLAB) is 16.63 and the Price/Book (PB) ratio is 1.74.